We are live on ! Find out more
BDWM

Brewin Dolphin Wealth Management Portfolio holdings

AUM $917M
1-Year Est. Return 12.3%
This Fund
S&P 500
This Quarter Est. Return
+10.17%
1 Year Est. Return
-12.3%
3 Year Est. Return
+47.8%
5 Year Est. Return
+88.28%
10 Year Est. Return
AUM
$823M
AUM Growth
+$168M
Cap. Flow
+$100M
Cap. Flow %
12.17%
Top 10 Hldgs %
56.65%
Holding
352
New
32
Increased
90
Reduced
37
Closed
17

Sector Composition

Rank Sector Weight
1 Financials 21.79%
2 Technology 12.73%
3 Healthcare 9.05%
4 Communication Services 8.26%
5 Consumer Discretionary 4.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLD icon
51
SPDR Gold Trust
GLD
$133B
$2.35M 0.29%
14,188
+13,858
+4,199% +$2.35M
PINS icon
52
Pinterest
PINS
$14.3B
$2.28M 0.28%
28,854
+15,404
+115% +$1.07M
KXI icon
53
iShares Global Consumer Staples ETF
KXI
$1.06B
$2.22M 0.27%
36,249
+12,050
+50% +$733K
DVY icon
54
iShares Select Dividend ETF
DVY
$23.7B
$2.2M 0.27%
18,850
-260
-1% -$30.9K
VZ icon
55
Verizon
VZ
$195B
$2.18M 0.26%
38,879
-3,379
-8% -$194K
SPGI icon
56
S&P Global
SPGI
$122B
$2.14M 0.26%
5,203
+2,911
+127% +$1.12M
ACWI icon
57
iShares MSCI ACWI ETF
ACWI
$33.4B
$1.87M 0.23%
18,510
-200
-1% -$19.9K
MMM icon
58
3M
MMM
$92.9B
$1.86M 0.23%
11,185
-120
-1% -$20K
CATH icon
59
Global X S&P 500 Catholic Values ETF
CATH
$1.34B
$1.86M 0.23%
34,784
-2,048
-6% -$107K
PM icon
60
Philip Morris
PM
$290B
$1.68M 0.2%
16,976
+66
+0.4% +$6.33K
QQQ icon
61
Invesco QQQ Trust
QQQ
$484B
$1.68M 0.2%
4,740
+395
+9% +$133K
BABA icon
62
Alibaba
BABA
$310B
$1.67M 0.2%
7,357
+1,205
+20% +$268K
PFE icon
63
Pfizer
PFE
$145B
$1.58M 0.19%
40,287
-13,790
-26% -$536K
BMY icon
64
Bristol-Myers Squibb
BMY
$135B
$1.55M 0.19%
23,250
+1,385
+6% +$90.3K
EWJ icon
65
iShares MSCI Japan ETF
EWJ
$22.4B
$1.42M 0.17%
20,959
+4,582
+28% +$313K
IPAY icon
66
Amplify Mobile Payments ETF
IPAY
$185M
$1.34M 0.16%
19,001
+6,295
+50% +$440K
IXJ icon
67
iShares Global Healthcare ETF
IXJ
$4.07B
$1.33M 0.16%
16,061
+813
+5% +$65.7K
CIBR icon
68
First Trust NASDAQ Cybersecurity ETF
CIBR
$15.2B
$1.27M 0.15%
27,220
+3,140
+13% +$140K
ABBV icon
69
AbbVie
ABBV
$430B
$1.26M 0.15%
11,180
MSCI icon
70
MSCI
MSCI
$41.6B
$1.25M 0.15%
2,348
+2,338
+23,380% +$1.11M
MCD icon
71
McDonald's
MCD
$191B
$1.12M 0.14%
4,860
+175
+4% +$40.7K
ESGE icon
72
iShares ESG Aware MSCI EM ETF
ESGE
$6.77B
$1.05M 0.13%
23,280
ACN icon
73
Accenture
ACN
$102B
$914K 0.11%
3,100
SYK icon
74
Stryker
SYK
$129B
$906K 0.11%
3,490
VWO icon
75
Vanguard FTSE Emerging Markets ETF
VWO
$123B
$887K 0.11%
+16,329
New +$870K

Similar funds

Brewin Dolphin Wealth Management's Q2 2021 Portfolio in Review

As of Q2 2021, Brewin Dolphin Wealth Management held 352 positions worth $823M, up 26% from $655M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Brewin Dolphin Wealth Management deployed $100M of net new capital in Q2 2021, opening 32 new positions and adding to 90 existing holdings. Its largest new stake was Vanguard FTSE Emerging Markets ETF: 16,329 shares worth $887K.

By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 21% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Pfizer, an estimated $536K trimmed.

  • Brewin Dolphin Wealth Management's largest Q2 2021 buy was Vanguard FTSE Emerging Markets ETF: 16,329 shares worth $887K.
  • Brewin Dolphin Wealth Management added most to Berkshire Hathaway Class B in Q2 2021, an estimated $9.24M increase.
  • Brewin Dolphin Wealth Management's biggest Q2 2021 reduction was Pfizer, cutting an estimated $536K.
  • Brewin Dolphin Wealth Management fully exited BioXcel Therapeutics in Q2 2021, selling an estimated $86.3K.
  • Brewin Dolphin Wealth Management's ten largest holdings make up 57% of its $823M portfolio in Q2 2021.
  • Brewin Dolphin Wealth Management opened 32 new positions and closed 17 in Q2 2021.
  • Brewin Dolphin Wealth Management's portfolio value rose 26% quarter-over-quarter to $823M.

Based on Brewin Dolphin Wealth Management's 13F filing for Q2 2021, filed 9 Nov 2023.